🟠 Moderate Evidence
Glycine, an amino acid widely marketed for sleep, collagen synthesis, and anti-aging benefits, has credible evidence for one clinical effect: reducing postprandial (after-meal) blood glucose spikes. A randomized controlled trial found that glycine ingestion reduced plasma glucose response by more than 50 percent when taken with a standard 25-gram glucose load, according to research published in the American Journal of Clinical Nutrition. However, the evidence for other marketed claims remains at the level of biological plausibility rather than human clinical proof.
Key takeaways
- Glycine reduced blood glucose response by more than 50% when paired with glucose, according to a 2002 randomized trial by Gannon and colleagues
- The mechanism appears to involve stimulation of insulin action and potentially gut hormone secretion, though the specific hormones were not identified in the original study
- Claims about glycine for collagen building and glutathione synthesis lack the randomized controlled trial evidence required to substantiate them in humans
- Sleep benefits of glycine are supported by evidence, distinguishing it from other wellness claims
Study at a Glance
| Source | American Journal of Clinical Nutrition |
| Study type | Randomized crossover trial |
| Sample size | N = 9 healthy adults |
| Population | Healthy adult volunteers |
| Country | United States |
Glycine’s Evidence Profile Across Health Claims
Strength of clinical evidence by marketed benefit, based on peer-reviewed trials
Source: Systematic review of glycine literature, GMJ News | 2026
The Glucose Study: A Modest Design, a Substantial Effect
In 2002, a research team led by investigators at the University of Connecticut conducted a randomized crossover trial that remains the most rigorous human evidence for glycine’s metabolic effects. The study enrolled nine healthy adults and tested four conditions on separate occasions: water alone, 25 grams of glucose alone, approximately 4 to 5.5 grams of glycine alone (calculated as 1 mmol per kilogram of lean body mass), and glycine combined with glucose.
Researchers measured plasma glucose, insulin, glucagon, and glycine concentrations for two hours after each intervention. According to the findings published in the American Journal of Clinical Nutrition, when participants ingested glycine with glucose, their blood glucose response was attenuated by more than 50 percent compared with glucose alone—a reduction that qualifies as a clinically meaningful effect size. The dose used was modest by supplement standards, and the 25-gram glucose challenge is the standard oral glucose tolerance test load, lending ecological validity to the findings.
The mechanism, while plausible, remains incompletely understood. According to Gannon’s data, glycine may stimulate secretion of a gut hormone that amplifies insulin’s action on glucose clearance from circulation. Glycine directly stimulates glucagon release, and there is biological plausibility for involvement of L-cell mediated incretin hormones (such as GLP-1), though the original paper did not identify the specific hormonal pathway. See Clinical Updates for related metabolic research.
Where the Evidence Stops: Collagen and Glutathione Claims
The wellness industry markets glycine for two additional benefits: collagen synthesis and glutathione production. Both have theoretical merit. Glycine comprises approximately 33 percent of collagen by amino acid composition, and it is a substrate for glutathione synthesis alongside cysteine and glutamate. However, as of 2026, no randomized controlled trials in humans have demonstrated that oral glycine supplementation increases collagen deposition or glutathione levels in measurable tissues.
This distinction matters. Biological plausibility—the idea that a mechanism could work—is the weakest form of evidence in clinical medicine. It is necessary but not sufficient. The absence of human RCTs means that marketed claims about collagen and anti-aging benefits operate in a regulatory grey zone where mechanism is assumed but outcome is unproven. Consumers purchasing glycine for these purposes are investing in hypothesis-level science, not validated clinical effects. This gap between plausibility and proof is explored in depth in the GMJ Explainers section.
Sleep Evidence: The Exception to the Pattern
Sleep is the one marketed benefit where glycine has moved beyond biological plausibility into clinical validation. Research, including a trial by Levy and colleagues published in Archives of General Psychiatry in 1999, demonstrated improvements in subjective sleep quality and sleep onset latency. This evidence base is modest but real—distinct from the collagen and glutathione claims, which have no human RCT support.
The implication is clear: glycine’s marketing narrative conflates evidence of different strengths. A compound can be a valid sleep aid while remaining unproven for collagen or glutathione synthesis. Consumers and clinicians should evaluate each claim independently against the actual evidence, not assume that credibility in one domain transfers to another. For an analysis of supplement marketing practices, refer to Pharmacy & Prescribing coverage.
Glycine reduced postprandial plasma glucose response by more than 50 percent when ingested with a standard 25-gram glucose load in a randomized crossover trial of nine healthy adults, suggesting a genuine metabolic effect on glucose homeostasis independent of other marketed claims.
— Gannon and colleagues, American Journal of Clinical Nutrition (2002)
What this means
Frequently asked questions
Is glycine safe to take daily?
Glycine is generally recognized as safe by regulatory authorities and is naturally present in protein-containing foods. The doses used in the Gannon trial (4–5.5 g) and in sleep studies are well-tolerated. However, safety at very high doses (above 10 g daily) has not been extensively studied in long-term trials, so routine daily supplementation should be discussed with a clinician, particularly for individuals with kidney disease or taking medications affecting glucose metabolism.
Why haven’t collagen and glutathione claims been tested in humans?
Testing these claims would require randomized trials measuring collagen deposition (via biopsy or imaging) or tissue glutathione levels after weeks to months of supplementation—expensive, invasive, and technically challenging studies. The wellness industry has instead relied on marketing based on collagen composition and glutathione biochemistry without funding the human trials needed to validate the claims. This reflects economic incentives rather than scientific barriers.
Should I take glycine with meals for blood glucose control?
The Gannon study tested glycine taken simultaneously with glucose, suggesting co-ingestion with carbohydrates may offer benefit. However, a single trial in nine healthy volunteers is insufficient to recommend clinical practice changes. Larger replication studies and trials in people with prediabetes or type 2 diabetes would be needed before glycine can be recommended as a diabetes management tool. Speak with your clinician before adding supplements to a diabetes regimen.
The glycine story illustrates a broader pattern in nutritional science: plausibility and proof are not the same. Glycine has earned genuine, if modest, evidence for sleep benefits and a credible (if unreplicated) finding for glucose control. For other marketed effects, the pathway is biological but the outcome is unproven—a distinction that matters when choosing supplements or evaluating health claims. Future research, particularly replication of the Gannon glucose trial in larger, more diverse populations, and properly powered trials of collagen and glutathione outcomes, will clarify whether glycine’s promise extends beyond the sleep evidence that currently anchors its use.
Source: Glycine marketing claims and evidence review
Was this article helpful?
Disclaimer. This article is health journalism intended for general information and education. It is not medical advice and is not a substitute for professional diagnosis or treatment. Always consult a qualified healthcare provider about your individual circumstances. Full disclaimer →
Related Coverage
Editorial standards. This article was produced under the GMJ News editorial process, with oversight by the GMJ Editorial Board. Our editorial process. Spotted an error? Contact the editorial team.
